Hedge funds significantly increased their aggregate long positions in Abbott Laboratories (ABT) during the first quarter of 2025, with total shares held by funds rising 43.67% from 11,968,872 to 17,195,314 between 12/31/2024 and 03/31/2025. This substantial accumulation, identified through analysis of recent 13F filings, suggests a notable collective bullish sentiment among institutional investors for ABT, warranting further research despite the inherent limitations of 13F data only disclosing long positions.
Analysis of 13F filings for the period ending March 31, 2025, reveals a significant increase in institutional ownership of Abbott Laboratories (ABT). Across a broad sample of 724 funds, aggregate holdings in ABT surged by 43.67%, with total shares increasing from 11.97 million to 17.20 million. This substantial accumulation indicates a strong, collective bullish sentiment among institutional managers during the first quarter. While a smaller, more recent batch of 21 filers showed mixed activity with 5 funds decreasing positions versus 3 increasing and 3 initiating new ones, the overwhelming aggregate trend points toward significant capital allocation to the stock. It is critical, however, to acknowledge the inherent limitation of 13F data, which only discloses long positions and may not reflect the full picture if funds are also employing bearish short strategies. Nevertheless, the scale of the net increase in long holdings strongly suggests that institutions are building conviction in ABT's forward-looking prospects.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment
